Authorized purpose: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
Clinical role
Triage and notification software whose AI algorithm analyzes CT chest images and flags studies with suspected multiple (3 or more) acute rib fractures on the radiologist's Studylist Application for prioritization, in parallel to standard of care.
Images and patients
CT/CTA · Chest/Lung
Key limitation
Keep in mind: Not diagnostic, does not alter original images, and chronic fractures, pseudoarthrosis, or malunion may be difficult to distinguish from acute fractures.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Chest/Lung Input: Chest CT images; performance data used slices greater than 1 mm from GE and Siemens scanners.
Who uses it?Intended users: Hospital networks and trained radiologists.
What does the software produce?Output: Passive Studylist or workstation notifications with compressed informational previews.
What is its most important limitation?Key limitation: Not diagnostic, does not alter original images, and chronic fractures, pseudoarthrosis, or malunion may be difficult to distinguish from acute fractures.
Clinical takeaway. Clinical role: Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
Evidence takeaway. Evidence from the reviewed source record: Blinded multicenter retrospective study of 200 cases reported sensitivity 92.7%, specificity 84.7%, AUC 0.939, and notification time 69.56 seconds for 76 true positives.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Provides notification-only parallel triage for chest CT studies suspected of multiple acute rib fractures.
Exact FDA submission
Checked 2026-09-15
Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.
Triage and notification software whose AI algorithm analyzes CT chest images and flags studies with suspected multiple (3 or more) acute rib fractures on the radiologist's Studylist Application for prioritization, in parallel to standard of care.
Exact FDA submission
Checked 2026-11-14
Packet wording: "uAI EasyTriage-Rib is a radiological computer-assisted triage and notification software device for analysis of CT chest images." … "uses an artificial intelligence algorithm to analyze images and highlight studies with suspected multiple (3 or more) acute rib fractures in a standalone application for study list prioritization or triage in parallel to ongoing standard of care.". Read from the exact FDA decision document on 2026-11-14.
Trauma CT chest studies; the device is intended to assist hospital networks and trained radiologists in workflow triage, and the FDA document does not further specify a facility type.
Exact FDA submission
Checked 2026-11-14
Packet wording: "for analysis of CT chest images. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and prioritizing trauma studies with suspected positive findings of multiple (3 or more) acute rib fractures.". Read from the exact FDA decision document on 2026-11-14.
Not diagnostic, does not alter original images, and chronic fractures, pseudoarthrosis, or malunion may be difficult to distinguish from acute fractures.
Blinded multicenter retrospective study of 200 cases reported sensitivity 92.7%, specificity 84.7%, AUC 0.939, and notification time 69.56 seconds for 76 true positives.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Blinded multicenter retrospective study of 200 cases reported sensitivity 92.7%, specificity 84.7%, AUC 0.939, and notification time 69.56 seconds for 76 true positives.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
uAI EasyTriage-Rib regulatory performance study summary
DesignStand-Alone Performance
PopulationPopulation described in the exact-submission ACR model card
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K193271
Samplen=200
IndependenceIndependence not established
K193271
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K193271. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Chest CT images; performance data used slices greater than 1 mm from GE and Siemens scanners.
Scope: Exact FDA submission. FDA packet input scope.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact FDA package describes DICOM data downloaded from the PACS for analysis, with notifications that include compressed preview images shown in the Studylist Application. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "The uAI EasyTriage-Rib time-to-notification is defined from the beginning of downloading the DICOM data from the PACS to the time of notification shown in the Studylist." … "Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes two modules, a uAI EasyTriage-Rib Server and a Studylist Application that shows notifications on the radiologist's workstations. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "The device consists of the following two modules: (1) uAI EasyTriage-Rib Server; and (2) uAI EasyTriage-Rib Studylist Application that provides the user interface in which notifications from the application are received." … "The subject device flags cases with the suspected positive findings on the Studylist Application on the workstations of the radiologist.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Passive Studylist or workstation notifications with compressed informational previews.
Scope: Exact FDA submission. FDA packet output scope.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes two modules, a uAI EasyTriage-Rib Server and a Studylist Application that shows notifications on the radiologist's workstations. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The device consists of the following two modules: (1) uAI EasyTriage-Rib Server; and (2) uAI EasyTriage-Rib Studylist Application that provides the user interface in which notifications from the application are received." … "The subject device flags cases with the suspected positive findings on the Studylist Application on the workstations of the radiologist.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The exact FDA package describes DICOM data downloaded from the PACS for analysis, with notifications that include compressed preview images shown in the Studylist Application. Interface versions and local compatibility require confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The uAI EasyTriage-Rib time-to-notification is defined from the beginning of downloading the DICOM data from the PACS to the time of notification shown in the Studylist." … "Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The 510(k) summary states uAI EasyTriage-Rib is intended to assist hospital networks and trained radiologists in workflow triage by flagging and prioritizing studies with suspected findings in chest CT images.
Exact FDA submission
Checked 2026-10-27
User qualification wording only; the summary specifies no training program or training offering for this device.
ACR AI Central provides an exact-submission model card for uAI EasyTriage-Rib; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
29Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission
No public price or quote for the exact K193271 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-09 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Chest CT (with or without contrast) triage and notification for suspected three or more acute rib fractures in adults or transitional adolescents age 18 or older; notifications are non-diagnostic and clinicians review the original study.
Authorized purpose: Chest and abdominal CT triage and notification for suspected vertebral compression fractures in the standard-of-care bone-health workflow; notifications are non-diagnostic and clinicians review the original study.
Authorized purpose: V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.
Authorized purpose: BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of CTPA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspected positive findings of Pulmonary Embolism (PE) pathologies. Briefcase uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a Stand-Alone Performance desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device. The results of BriefCase are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.